Cytox

Developing transformational prognostic technology that may contribute to the assessment of an individual's risk of developing dementias such as Alzheimer's disease.

Launch date

Jun 2004

Employees

2-10 people

Market cap

Enterprise valuation

Company register number 05149130

Oxford England (HQ)

http://cytoxgroup.com

https://twitter.com/cytoxdx https://www.facebook.com/cytoxdx https://www.linkedin.com/company/cytox-limited

Date	Investors	Amount	Round
-	Oxford University Innovation CRT Pioneer Fund GWC Oxford Investment Consultants OUI Startup Incubator	N/A	-
Jan 2004	University of Oxford	N/A	Spinout
Jun 2009	Qi3 Ventures Masa Life Science Fund	£600k	Seed
Jan 2013	Wren Capital Jim Mellon SPARK Impact Esperante Ventures	£3.5m	Series A
Apr 2014	Midven Wren Capital Seneca Partners Walking Ventures	£1.5m	Series A
Apr 2015	N/A	£1.3m	Grant
Jun 2017	UK Innovation & Science Seed Fund Perivoli Innovations GM&C Life Sciences Fund	£2.6m	Series B
Mar 2018	N/A	£800k	Grant
Dec 2018	European Innovation Council	€50.0k	Grant
Total Funding		€12.4m

Tech stackLearn more about the technologies and tools that this company uses.

Cytox

Cytox

Related Content

Recent News about Cytox

Tech stack